Platelet Aggregation System Market Scope
Platelet aggregation systems also known as an aggregometer can be used to determine how well platelets stick together. Furthermore, a platelet aggregation system can encompass several test modes where the number of channels available in an aggregometer is equivalent to the number of tests that can be run simultaneously and independently. Rising incidences of target diseases, rapid growth in the geriatric population across the world, technological advancements in platelet aggregometers, and increasing number of industry-academia collaborations and clinical studies these are the key factors boosting the growth of the market
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Largest Market | North America |
Unit | Value (USD Million) |
Key Companies Profiled | Haemonetics Corporation (United States), Sysmex Corporation (Japan), Siemens AG (Germany), Accriva Diagnostics (United States), Helena Laboratories Corporation (United States), Bio/Data Corporation (United States), Sentinel CH. S.p.A. (Italy) and Aggredyne, Inc. (United States) |
CAGR | % |
Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Platelet Aggregation System market throughout the predicted period.
Haemonetics Corporation (United States), Sysmex Corporation (Japan), Siemens AG (Germany), Accriva Diagnostics (United States), Helena Laboratories Corporation (United States), Bio/Data Corporation (United States), Sentinel CH. S.p.A. (Italy) and Aggredyne, Inc. (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Brennan & Company (Ireland) and F. Hoffmann La-Roche Ltd. (Switzerland).
About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.
Segmentation Overview
The study have segmented the market of Global Platelet Aggregation System market by Type , by Application (Research Applications, Clinical Applications, Cardiovascular Applications, Orthopedic Applications and Others) and Region with country level break-up. On the basis of Type, Eight-Channel are dominating the market in the year 2023 where as Four-Channel stood as second largest market share.
On the basis of application, Clinical Applications segment is dominating the market in the year 2023 where as Cardiovascular Applications segment stood as second largest market.
On the basis of geography, the market of Platelet Aggregation System has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2023. Asia Pacific on the other hand stood as second largest market due to the presence of key companies into the region and high technological advancement.
In August , 2018, Sysmex America Inc., Sysmex Corporation’s regional headquarters for the Americas, has opened the Center for Learning (“CFL”). In response to growing demand for virtual training in line with business expansion in North America (the United States and Canada), this recently expanded support base consolidates into a single location training functions targeting customers and Sysmex America’s own technical staff.
FDA's Center for Devices and Radiological Health (CDRH) is responsible for regulating firms who manufacture, repackage, relabel, and/or import medical devices sold in the United States. In addition, CDRH regulates radiation-emitting electronic products (medical and non-medical) such as lasers, x-ray systems, ultrasound equipment and others. Manufacturers (both domestic and foreign) and initial distributors (importers) of medical devices must register their establishments with the FDA.
Influencing Trend:
Adoption of Technologically Advanced product in Platelet Aggregation System
Market Growth Drivers:
Rising Aged Population Across the developed economies and Increasing Incidence of Target Diseases in Asia Pacific regions including China, India and Japan.
Challenges:
Limited Medical Compensations and Strict Regulatory Policies
Restraints:
Hostile Healthcare Reforms in the United States and Lack of Well-Trained, Skilled, and Suitable Professionals
Opportunities:
Increasing demand of platelet aggregation system due to growing number of surgical procedures.
Key Target Audience
Manufacturers of Platelet Aggregation System, Suppliers of Platelet Aggregation System Parts, Distributers and Retailers of Platelet Aggregation System, Hospitals and Health Cares and Government Bodies